{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:32:16Z","timestamp":1792931536020,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55180-x","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T03:16:11Z","timestamp":1779765371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["QT-prolonging antipsychotic combinations and associated risk in hospitalized patients with mental disorders in Sana\u2019a, Yemen"],"prefix":"10.1038","volume":"16","author":[{"given":"Mohammed A.","family":"Al-Khawlani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa M.","family":"Al-Madhagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olla","family":"Sharhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan N.","family":"Al-Obydi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawheeb A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Dabwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"AL-Farga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"2","key":"55180_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jsps.2022.12.004","volume":"31","author":"Y Chen","year":"2023","unstructured":"Chen, Y. & Ding, L. Potential drug-drug interactions in outpatients with depression of a psychiatry department. Saudi Pharm. J. 31(2), 207\u2013213 (2023).","journal-title":"Saudi Pharm. J."},{"issue":"15","key":"55180_CR2","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","volume":"142","author":"JE Tisdale","year":"2020","unstructured":"Tisdale, J. E. et al. Drug-induced arrhythmias: A scientific statement from the American Heart Association. Circulation 142(15), e214\u2013e233 (2020).","journal-title":"Circulation"},{"issue":"1","key":"55180_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12888-020-02687-w","volume":"20","author":"Z Ali","year":"2020","unstructured":"Ali, Z. et al. Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: A prospective observational study. BMC Psychiatry 20(1), 277 (2020).","journal-title":"BMC Psychiatry"},{"issue":"4","key":"55180_CR4","doi-asserted-by":"publisher","first-page":"pyu080","DOI":"10.1093\/ijnp\/pyu080","volume":"18","author":"CJ Spindelegger","year":"2015","unstructured":"Spindelegger, C. J. et al. Cardiovascular adverse reactions during antidepressant treatment: A drug surveillance report of German-speaking countries between 1993 and 2010. Int. J. Neuropsychopharmacol. 18(4), pyu080 (2015).","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"9","key":"55180_CR5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.hrthm.2020.05.008","volume":"17","author":"L Jankelson","year":"2020","unstructured":"Jankelson, L., Karam, G., Becker, M. L., Chinitz, L. A. & Tsai, M.-C. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review. Heart Rhythm 17(9), 1472\u20131479 (2020).","journal-title":"Heart Rhythm"},{"issue":"1","key":"55180_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/08971900221121371","volume":"37","author":"SK Ramasubbu","year":"2024","unstructured":"Ramasubbu, S. K., Mishra, A. & Mandal, S. Prevalence of QT-prolonging drug-drug interactions in psychiatry: A systematic review and meta analysis. J. Pharm. Pract. 37(1), 162\u2013168 (2024).","journal-title":"J. Pharm. Pract."},{"issue":"10","key":"55180_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden, D. M. Drug-induced prolongation of the QT interval. N. Engl. J. Med. 350(10), 1013\u20131022 (2004).","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"55180_CR8","first-page":"473","volume":"42","author":"M Li","year":"2017","unstructured":"Li, M. & Ramos, L. G. Drug-induced QT prolongation and torsades de pointes. Pharm. Ther. 42(7), 473 (2017).","journal-title":"Pharm. Ther."},{"issue":"19","key":"55180_CR9","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1161\/CIR.0000000000000527","volume":"136","author":"KE Sandau","year":"2017","unstructured":"Sandau, K. E. et al. Update to practice standards for electrocardiographic monitoring in hospital settings: A scientific statement from the American Heart Association. Circulation 136(19), e273\u2013e344 (2017).","journal-title":"Circulation"},{"issue":"12","key":"55180_CR10","doi-asserted-by":"publisher","first-page":"e007724","DOI":"10.1161\/JAHA.117.007724","volume":"6","author":"A Porta\u2010S\u00e1nchez","year":"2017","unstructured":"Porta\u2010S\u00e1nchez, A. et al. Incidence, diagnosis, and management of QT prolongation induced by cancer therapies: A systematic review. J. Am. Heart Assoc. 6(12), e007724 (2017).","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"55180_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.psym.2017.10.009","volume":"59","author":"SR Beach","year":"2018","unstructured":"Beach, S. R. et al. QT prolongation, torsades de pointes, and psychotropic medications: A 5-year update. Psychosomatics 59(2), 105\u2013122 (2018).","journal-title":"Psychosomatics"},{"issue":"2","key":"55180_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00702-020-02291-y","volume":"128","author":"G Hefner","year":"2021","unstructured":"Hefner, G. et al. Pharmacodynamic drug\u2013drug interactions of QT-prolonging drugs in hospitalized psychiatric patients. J. Neural Transm. 128(2), 243\u2013252 (2021).","journal-title":"J. Neural Transm."},{"issue":"9","key":"55180_CR13","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1016\/S1470-2045(22)00221-2","volume":"23","author":"EL Giraud","year":"2022","unstructured":"Giraud, E. L. et al. The QT interval prolongation potential of anticancer and supportive drugs: A comprehensive overview. Lancet Oncol. 23(9), e406\u2013e415 (2022).","journal-title":"Lancet Oncol."},{"issue":"2","key":"55180_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1542-474X.1997.tb00325.x","volume":"2","author":"HC Bazett","year":"1997","unstructured":"Bazett, H. C. An analysis of the time\u2010relations of electrocardiograms. Ann. Noninvasive Electrocardiol. 2(2), 177\u2013194 (1997).","journal-title":"Ann. Noninvasive Electrocardiol."},{"issue":"10","key":"55180_CR15","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1161\/CIRCULATIONAHA.108.191096","volume":"119","author":"PM Rautaharju","year":"2009","unstructured":"Rautaharju, P. M., Surawicz, B. & Gettes, L. S. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part IV: The ST segment, T and U waves, and the QT interval: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology. Circulation 119(10), e241\u2013e250 (2009).","journal-title":"Circulation"},{"issue":"2","key":"55180_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.annemergmed.2014.12.005","volume":"66","author":"I Berling","year":"2015","unstructured":"Berling, I. & Isbister, G. K. Prolonged QT risk assessment in antipsychotic overdose using the QT nomogram. Ann. Emerg. Med. 66(2), 154\u2013164 (2015).","journal-title":"Ann. Emerg. Med."},{"key":"55180_CR17","doi-asserted-by":"crossref","unstructured":"Redfern, W. S. et al. Relationships between preclinical cardiacelectrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for aprovisional safety margin in drug development. Cardiovasc. Res. 58, 32\u201345 (2003).","DOI":"10.1016\/S0008-6363(02)00846-5"},{"key":"55180_CR18","unstructured":"Al-Akchar, M., Siddique, M. S. Long QT syndrome. In StatPearls [Internet]. [Updated 2022 Dec 26]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441860\/ (StatPearls Publishing, Treasure Island(FL), 2024)."},{"issue":"1","key":"55180_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jemermed.2017.08.073","volume":"54","author":"HN Anderson","year":"2018","unstructured":"Anderson, H. N. et al. Prevalence and outcome of high-risk QT prolongation recorded in the emergency department from an institution-wide QT alert system. J. Emerg. Med. 54(1), 8\u201315 (2018).","journal-title":"J. Emerg. Med."},{"issue":"1","key":"55180_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/IJCIIS.IJCIIS_59_17","volume":"8","author":"CL Birda","year":"2018","unstructured":"Birda, C. L., Kumar, S., Bhalla, A., Sharma, N. & Kumari, S. Prevalence and prognostic significance of prolonged QTc interval in emergency medical patients: A prospective observational study. Int. J. Crit. Illn. Inj. Sci. 8(1), 28\u201335 (2018).","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"key":"55180_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2024.07.035","volume":"272","author":"MWH Lochmann van Bennekom","year":"2024","unstructured":"Lochmann van Bennekom, M. W. H. et al. Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data. Schizophr. Res. 272, 1\u201311 (2024).","journal-title":"Schizophr. Res."},{"issue":"1","key":"55180_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/neurolint14010024","volume":"14","author":"AN Edinoff","year":"2022","unstructured":"Edinoff, A. N. et al. Antipsychotic polypharmacy-related cardiovascular morbidity and mortality: A comprehensive review. Neurol. Int. 14(1), 294\u2013309 (2022).","journal-title":"Neurol. Int."},{"issue":"3","key":"55180_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/JCP.0000000000001671","volume":"43","author":"MA Lee","year":"2023","unstructured":"Lee, M. A., Cola, P., Jayathilake, K. & Meltzer, H. Y. Long-term outcome of clozapine in treatment-resistant schizophrenia. J. Clin. Psychopharmacol. 43(3), 211\u2013219 (2023).","journal-title":"J. Clin. Psychopharmacol."},{"key":"55180_CR24","doi-asserted-by":"publisher","first-page":"204512531989138","DOI":"10.1177\/2045125319891386","volume":"9","author":"N Ansermot","year":"2019","unstructured":"Ansermot, N. et al. Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients. Ther. Adv. Psychopharmacol. 9, 2045125319891386 (2019).","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1","key":"55180_CR25","first-page":"21m02915","volume":"24","author":"B Salvati","year":"2022","unstructured":"Salvati, B. et al. Prevalence and risk factors for QTc prolongation in acute psychiatric hospitalization. Prim. Care Companion CNS Disord. 24(1), 21m02915 (2022).","journal-title":"Prim. Care Companion CNS Disord."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55180-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:45:12Z","timestamp":1785800712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55180-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55180"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55180-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8928654\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Research Committee of Al-Nasser University (Code: NU-RECM2309). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23960"}}